美國
證券與交易委員會
華盛頓特區 20549
13G表
根據1934年證券交易法
（修訂編號。）
| Dianthus Therapeutics公司 |
| （發行人名稱） |
| 普通股，每股0.001美元面值 |
| （證券種類名稱） |
| 252828108 | ||
| （CUSIP編號） | ||
| 2024年9月30日 | ||
| （需要提交此聲明的事件日期）。 | ||
請勾選適當的方框以指定根據哪條規則提交此安排表:
| x | 13d-1（b）規則 | |
| o | 13d-1（c）規則 | |
| o | 13d-1（d）規則 |
本封面其餘部分應填寫對於報告人首次提交關於所涉證券的類別的信息以及任何後續修改的表格，該修改包含了在原先的封面中所提供的信息。
本封面剩餘部分所需的信息並不被視爲根據《1934年證券交易法》（「法案」）18條的「已備案」或其他受到該法案該條款責任制約的內容，但將受到該法案的所有其他規定的約束（但請參見注釋）。
| 頁面 1 9之1 |
| CUSIP編號：252828108 | ||
| 1 |
報告人的名稱 報告人的納稅人識別號碼（僅限實體）
普通股，每股票面價值0.00001美元（「普通股」） | |
| 2 |
如果是組合成員，請勾選適用的框（請參閱說明）
|
(a)o (b)o |
| 3 |
SEC® 僅限使用
| |
| 4 |
公民身份或組織地點
特拉華州 | |
|
持有的受益股份數量 每個報告人持有的受益股份數量 有益的 擁有人 每個報告人的： 持有： |
5 |
唯一擁有投票權的股份數量
0 |
| 6 |
具有共同投票權
1,746,667 | |
| 7 |
具有唯一處理權
0 | |
| 8 |
具有共同處理權
1,746,667 |
| 9 |
每位報告人受益擁有的合計數量
1,746,667 |
| 10 |
如果第九行的合計金額不包括某些股票，請勾選方框（見說明書）
o |
| 11 |
第9行金額佔整個類別的百分比
6.0% |
| 12 |
報告人類型（請參閱說明）
IA，PN |
| 頁面 2 9之1 |
| CUSIP編號：252828108 | ||
| 1 |
報告人的名稱 報告人的納稅人識別號碼（僅限實體）
八角投資主基金有限合夥 | |
| 2 |
如果是組合成員，請勾選適用的框（請參閱說明）
|
(a)o (b)o |
| 3 |
SEC® 僅限使用
| |
| 4 |
公民身份或組織地點
開曼群島 | |
|
持有的受益股份數量 每個報告人持有的受益股份數量 有益的 擁有人 每個報告人的： 持有： |
5 |
唯一擁有投票權的股份數量
0 |
| 6 |
具有共同投票權
1,455,000 | |
| 7 |
具有唯一處理權
0 | |
| 8 |
具有共同處理權
1,455,000 |
| 9 |
每位報告人受益擁有的合計數量
1,455,000 |
| 10 |
如果第九行的合計金額不包括某些股票，請勾選方框（見說明書）
o |
| 11 |
第9行金額佔整個類別的百分比
5.0% |
| 12 |
報告人類型（請參閱說明）
OO，PN |
| 頁面 3 9之1 |
| CUSIP編號：252828108 | ||
| 1 |
報告人的名稱 報告人的納稅人識別號碼（僅限實體）
八角私人機會基金II 有限合夥 | |
| 2 |
如果是組合成員，請勾選適用的框（請參閱說明）
|
(a)o (b)o |
| 3 |
SEC® 僅限使用
| |
| 4 |
公民身份或組織地點
特拉華州 | |
|
持有的受益股份數量 每個報告人持有的受益股份數量 有益的 擁有人 每個報告人的： 持有： |
5 |
唯一擁有投票權的股份數量
0 |
| 6 |
具有共同投票權
291,667 | |
| 7 |
具有唯一處理權
0 | |
| 8 |
具有共同處理權
291,667 |
| 9 |
每位報告人受益擁有的合計數量
291,667 |
| 10 |
如果第九行的合計金額不包括某些股票，請勾選方框（見說明書）
o |
| 11 |
第9行金額佔整個類別的百分比
1.0% |
| 12 |
報告人類型（請參閱說明）
OO，PN |
| 頁面 4 9之1 |
| CUSIP 編號 252828108 | ||
| 1 |
舉報人姓名 美國國稅局身份證號上述人員（僅限實體）
賈婷 | |
| 2 |
如果是群組的成員，請選中相應的複選框（參見說明）
|
(a)o (b)o |
| 3 |
秒® 僅使用
| |
| 4 |
公民身份或組織地點
中國 | |
|
持有的受益股份數量 每個報告人持有的受益股份數量 有益的 擁有人 每個報告人的： 持有： |
5 |
唯一擁有投票權的股份數量
0 |
| 6 |
具有共同投票權
1,746,667 | |
| 7 |
具有唯一處理權
0 | |
| 8 |
具有共同處理權
1,746,667 |
| 9 |
每位報告人受益擁有的合計數量
1,746,667 |
| 10 |
如果第九行的合計金額不包括某些股票，請勾選方框（見說明書）
o |
| 11 |
第9行金額佔整個類別的百分比
6.0% |
| 12 |
報告人類型（請參閱說明）
HC，印度 |
| 頁面 5 9之1 |
| 項目1（a）。 | 發行人名稱： |
| Dianthus Therapeutics公司 | |
| 項目1(b)。 | 發行人主要執行辦公室的地址： |
| 7 帝國廣場，43號rd 樓，紐約，紐約10036 | |
| 項目2(a)。 | 申報人姓名： |
|
此聲明由以下各方聯合提交：
Octagon Capital Advisors LP（"Octagon"） 八角形投資控股企業基金有限合夥（"控股企業 基金"） Octagon私人機會基金II LP（" 私人 基金 II"） 汪嘉，作爲八角形的主要受益所有人（"嘉先生"）
上述每個被稱爲"報告人" 集體稱爲"報告人"
Octagon擔任主基金和私人基金II的投資經理。賈先生是Octagon的管理成員。由於這些關係，Octagon和賈先生可能被認定爲受益擁有主基金和私人基金II直接擁有的發行人普通股。
| |
| 第2(b)項。 | 主要業務地點或居住地地址： |
| 每個報告人的辦公地址爲麥迪遜大道654號，21樓21世紀醫療改革法案 紐約，NY 10065 | |
| 第2(c)項。 | 國籍： |
| Octagon是一家特拉華州有限合夥。主要基金是在開曼群島成立的免稅有限合夥。第二私募基金是特拉華州有限合夥。賈先生是中國公民。 | |
| 第2(d)項。 | 證券種類名稱： |
| 普通股，$0.001面值（"普通股" | |
| 第2(e)項。 | CUSIP編號: 252828108 |
| Page 6 of 9 |
| Item 3. | If this Statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | ||
| (a) | o | Broker or dealer registered under Section 15 of the Act; | |
| (b) | o | Bank as defined in Section 3(a)(6) of the Act; | |
| (c) | o | Insurance company as defined in Section 3(a)(19) of the Act; | |
| (d) | o | Investment company registered under Section 8 of the Investment Company Act of 1940; | |
| (e) | x | An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); | |
| (f) | o | An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); | |
| (g) | x | A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); | |
| (h) | o | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
| (i) | o | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; | |
| (j) | o | A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); | |
| (k) | o | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: | |
| Item 4. | Ownership. | |||
| Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. | ||||
| (a) | Amount Beneficially Owned: | 1,746,667 | ||
| (b) |
Percent of Class: |
6.0% | ||
| The percentage reported on this Schedule 13G is calculated based upon 29,354,320 Common Stock outstanding as of August 6, 2024, as reported in the Form 10-Q filed by the Issuer on August 8, 2024. | ||||
| (c) | Number of shares as to which such person has: | |||
| (i) | sole power to vote or to direct the vote: | 0 | ||
| (ii) | shared power to vote or to direct the vote: | 1,746,667 | ||
| (iii) | sole power to dispose or to direct the disposition of: | 0 | ||
| (iv) | shared power to dispose or to direct the disposition of: | 1,746,667 | ||
| Page 7 of 9 |
| Item 5. | Ownership of Five Percent or Less of a Class. |
| If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o. | |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
| Octagon is the investment advisor to the Master Fund, the Private Fund II and other accounts. Mr. Jia is the control person of Octagon. The Master Fund holds the Common Stock for the benefit of its investors. The Private Fund II holds the Common Stock for the benefit of its investors. The Master Fund, the Private Fund II and Octagon, for the benefit of its investors, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. | |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. |
| Not applicable. | |
| Item 8. | Identification and Classification of Members of the Group. |
| Not applicable. | |
| Item 9. | Notice of Dissolution of Group. |
| Not applicable. | |
| Item 10. | Certification. |
| By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. |
| Page 8 of 9 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: October 11, 2024 | OCTAGON CAPITAL ADVISORS LP | |
| /s/ Ting Jia | ||
| Name: | Ting Jia | |
| Title: | Managing Member | |
|
OCTAGON INVESTMENTS MASTER FUND LP | ||
| By: Octagon Investments GP, LLC, its general partner | ||
| /s/ Ting Jia | ||
| Name: | Ting Jia | |
| Title: | Managing Member | |
|
OCTAGON PRIVATE OPPORTUNITIES FUND II LP | ||
| By: Octagon Investments GP, LLC, its general partner | ||
| /s/ Ting Jia | ||
| Name: | Ting Jia | |
| Title: | Managing Member | |
TING JIA | ||
| /s/ Ting Jia | ||
| Name: | Ting Jia | |
Page 9 of 9